Roche announces the filing for FDA Emergency Use Authorization for SARS-CoV-2 Rapid Antigen Test, allowing healthcare professionals to make fast decisions at the point of care ...Middle East

INDIANAPOLIS, Feb. 8, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the submission for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a SARS-CoV-2 Rapid Antigen Test that is designed for use by healthcare professionals in...

Hence then, the article about roche announces the filing for fda emergency use authorization for sars cov 2 rapid antigen test allowing healthcare professionals to make fast decisions at the point of care was published today ( Monday 08/02/2021 - 08:15 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Roche announces the filing for FDA Emergency Use Authorization for SARS-CoV-2 Rapid Antigen Test, allowing healthcare professionals to make fast decisions at the point of care )

Also on site :

• Suburban teen charged in Near North hit-and-run wrong-way crash
• Taylor Swift’s Wedding Comes Together As Crews Load In Gazebo, Watch!
• Odisha Cabinet Approves 12 Key Proposals